SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284852
Filing Date
2015-08-10
Accepted
2015-08-10 16:08:55
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d946600d10q.htm 10-Q 314819
2 EX-31.1 d946600dex311.htm EX-31.1 8241
3 EX-31.2 d946600dex312.htm EX-31.2 8226
4 EX-32.1 d946600dex321.htm EX-32.1 3546
5 EX-32.2 d946600dex322.htm EX-32.2 3490
  Complete submission text file 0001193125-15-284852.txt   2560009

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20150630.xml EX-101.INS 425360
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20150630.xsd EX-101.SCH 38043
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20150630_cal.xml EX-101.CAL 47911
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20150630_def.xml EX-101.DEF 110880
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20150630_lab.xml EX-101.LAB 289806
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20150630_pre.xml EX-101.PRE 198579
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 151040822
SIC: 2834 Pharmaceutical Preparations